SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-15-017193
Filing Date
2015-09-11
Accepted
2015-09-11 16:43:33
Documents
18
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K bota20150630_10k.htm 10-K 2239874
2 EXHIBIT 21.1 ex21-1.htm EX-21.1 4276
3 EXHIBIT 23.1 ex23-1.htm EX-23.1 3558
4 EXHIBIT 23.1A ex23-1a.htm EX-23.1A 3446
5 EXHIBIT 23.2 ex23-2.htm EX-23.2 5372
6 EXHIBIT 31.1 ex31-1.htm EX-31.1 11074
7 EXHIBIT 31.2 ex31-2.htm EX-31.2 11247
8 EXHIBIT 32.1 ex32-1.htm EX-32.1 4928
9 EXHIBIT 32.2 ex32-2.htm EX-32.2 4858
16 a3.jpg GRAPHIC 49278
17 a2.jpg GRAPHIC 43766
18 a1.jpg GRAPHIC 68079
  Complete submission text file 0001437749-15-017193.txt   8371638

Data Files

Seq Description Document Type Size
10 EXHIBIT 101.INS bota-20150630.xml EX-101.INS 1604284
11 EXHIBIT 101.SCH bota-20150630.xsd EX-101.SCH 66925
12 EXHIBIT 101.CAL bota-20150630_cal.xml EX-101.CAL 64869
13 EXHIBIT 101.DEF bota-20150630_def.xml EX-101.DEF 458663
14 EXHIBIT 101.LAB bota-20150630_lab.xml EX-101.LAB 381733
15 EXHIBIT 101.PRE bota-20150630_pre.xml EX-101.PRE 497999
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-35285 | Film No.: 151103719
SIC: 2836 Biological Products, (No Diagnostic Substances)